Article

Insomnia and the Risk of Acute Myocardial Infarction A Population Study

Department of Public Health, Faculty of Medicine, Trondheim, Norway.
Circulation (Impact Factor: 14.95). 11/2011; 124(19):2073-81. DOI: 10.1161/CIRCULATIONAHA.111.025858
Source: PubMed

ABSTRACT Few prospective studies have investigated insomnia in relation to risk for coronary heart disease. We assessed insomnia symptoms and risk of acute myocardial infarction (AMI) in a large, population-based study.
A total of 52 610 men and women were followed up for a first AMI, and 2368 incident AMIs occurred during 11.4 years of follow-up, either identified at hospitals or by the National Cause of Death Registry. In our analyses, we adjusted for age, sex, marital status, education, shift work, blood pressure, lipids, diabetes mellitus, body mass index, physical activity, smoking, and alcohol consumption. Difficulties initiating and maintaining sleep and having a feeling of nonrestorative sleep were associated with a moderate increase in AMI risk. The multiadjusted hazard ratios for AMI were 1.45 (95% confidence interval 1.18-1.80) for people with difficulties initiating sleep almost every night, 1.30 (1.01-1.68) for those with difficulties maintaining sleep almost every night, and 1.27 (1.03-1.57) for those with a feeling of nonrestorative sleep more than once a week compared with people who never experienced these sleep difficulties. When we combined the symptoms, a dose-dependent association was seen between the number of insomnia symptoms and AMI risk (P for trend 0.003). Alternative multivariable models and different sensitivity analyses suggest that the results were robust, especially concerning difficulties initiating sleep.
Insomnia is associated with a moderately increased risk for AMI.

0 Followers
 · 
129 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Studies investigating the relationship between sleep disorders (SDs) and the risk of venous thromboembolism (VTE) are scarce. The present study from Taiwan evaluated whether the risk of VTE was associated with SDs other than sleep apnea. The present study investigated the incidence and risk of VTE in 46,371 people with SDs, compared with 92,742 controls without SDs. The follow-up period began from the date of entering the study cohort to the date of a VTE event, censoring, or December 31, 2011. A Cox proportional hazards regression analysis was conducted to estimate the effects of SDs on the risk of VTE. The SD cohort had a 1.79-fold adjusted hazard ratio (HR) of subsequent VTE, compared with the non-SD cohort (95% CI 1.49-2.16). The incidence of VTE increased with age for both cohorts but was higher for those in the SD cohort. However, the adjusted HRs for VTE were significantly higher for the people with SDs aged ≦49 years (HR 3.29, 95% CI 2.12-5.12) and 50-64 years (HR 2.43, 95% CI 1.76-3.35), but were not significant for the oldest group (HR 1.11, 95% CI 0.84-1.47), compared with the controls. The multiplicative increased risk of VTE was significant for the people with SDs with any comorbidity. This nationwide cohort study determined that the VTE risk significantly increased in people with SDs compared with those of the general population. Copyright © 2014 Elsevier B.V. All rights reserved.
    Sleep Medicine 11/2014; 16(1). DOI:10.1016/j.sleep.2014.07.031 · 3.10 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Short sleep and poor sleep quality are associated with risk of cardiovascular disease, diabetes, cancer, and mortality. This study examines the contribution of sleep duration and sleep quality on a multisystem biological risk index that is known to be associated with morbidity and mortality. Analyses include a population-based sample from the Midlife Development in the United States survey recruited to the Biomarker substudy. A total of 1,023 participants aged 54.5 years (SD = 11.8), 56% female and 77.6% white, were included in the analyses. A multisystem biological risk index was derived from 22 biomarkers capturing cardiovascular, immune, lipid-metabolic, glucose-metabolic, sympathetic, parasympathetic, and hypothalamic-pituitary-adrenal systems. Self-reported average sleep duration was categorized as short (<5 hrs), below normal (5 to <6.5 hrs), normal (6.5 to <8.5 hrs), and long sleepers (8.5+ hrs). Sleep quality was determined using the Pittsburgh Sleep Quality Index categorized as normal (≤5) and poor quality (>5) sleep. Linear mixed effect models adjusting for age, gender, race, education, income, BMI, and health status were performed. As compared to normal sleepers, multisystem biological risk in both short (B(SE) = .38(.15), p<.01) and long sleepers (B(SE) = .28(.11), p<.01) were elevated. Poor quality sleep alone was associated with elevated multisystem biological risk (B(SE) = .15(.06), p = .01), but was not significant after adjustment for health status. All short sleepers reported poor sleep quality. However in the long sleepers, only those who reported poor sleep quality exhibited elevated multisystem biological risk (B(SE) = .93(.3), p = .002). Self-reported poor sleep quality with either short or long sleep duration is associated with dysregulation in physiological set points across regulatory systems, leading to elevated multisystem biological risk. Physicians should inquire about sleep health in the assessment of lifestyle factors related to disease risk, with evidence that healthy sleep is associated with lower multisystem biological risk.
    PLoS ONE 02/2015; 10(2):e0118467. DOI:10.1371/journal.pone.0118467 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Using the 2008 National Study of the Changing Workforce, we study how two forms of flextime correlate with family stress, workplace stress, and sleep difficulties. The first flextime measure is the ability to easily take time off for personal and family matters, which correlates with a statistically and economically significant reduction in workplace stress. Subsequently, we find that this same flexibility is associated with 6–10 % reduction in the likelihood of self-reported sleep difficulties for the full sample, and as high as an 11–25 % reduction in a subgroup analysis concerning unmarried females with children. The second flextime measure is the option of a compressed workweek, which also correlates with a statistically reduction in workplace stress, though the estimate is considerably smaller than for the first flexibility; a subsequent analysis finds no statistically significant relationship between this flexibility and sleep difficulties. Our findings suggest that the more flexible flexibility (i.e., more short-notice schedule flexibility) appears to be associated with larger reductions in the probability of being stressed, enough, in fact, to carry through to noticeable improvements in concomitant sleep difficulties. Thus, the first form of flextime may function, based on this observational analysis, as a tangible non-medical way to meet worker flextime desires and firm aspirations for increased safety and less absenteeism, all while potentially offering a positive public health externality. The size and significance of the flextime results prevail through bias assessments and sensitivity analyses.
    Empirical Economics 06/2014; 48(4). DOI:10.1007/s00181-014-0836-4 · 0.60 Impact Factor